Literature DB >> 9200691

Roles of the structure and orientation of ligands and ligand mimics inside the ligand-binding pocket of the vitamin D-binding protein.

N Swamy1, A Dutta, R Ray.   

Abstract

1alpha,25-Dihydroxyvitamin D3, the vitamin D hormone, manifests its diverse biological properties by specifically binding to the vitamin D sterol-binding pockets of vitamin D-binding protein (DBP) and vitamin D receptor. In the past, several affinity, photoaffinity, and chemical modification studies have been carried out to probe the vitamin D sterol-binding pocket of DBP and to evaluate the relationship between the structure of this pocket and the functions of the protein. In the present study, we examined the steric requirements inside this pocket by considering conformational structures of various bromoacetate derivatives of 25-hydroxyvitamin D3 and 1alpha,25-dihydroxyvitamin D3 and their abilities to covalently and specifically modify this pocket. We observed that, although 25-hydroxyvitamin D3 3beta-bromoacetate (25-OH-D3-3-BE), 1alpha,25-dihydroxyvitamin D3 3beta-bromoacetate [1alpha,25(OH)2D3-3-BE], 1alpha,25-dihydroxyvitamin D3 1alpha-bromoacetate [1alpha,25(OH)2D3-1-BE], and 1alpha,25-dihydroxyvitamin D3 1alpha,3beta-dibromoacetate [1alpha,25(OH)2D3-1,3-di-BE] bound DBP in a specific manner, only [3H]-25-OH-D3-3-BE and [3H]-1alpha,25(OH)2D3-3-BE affinity labeled the protein. BNPS-skatole cleavages of [3H]-25-OH-D3-3-BE- and 3H-1alpha,25(OH)2D3-3-BE-labeled DBP samples produced the same labeled peptide (N-terminal), demonstrating the specificity of labeling by these analogs. Energy-minimized conformational structures of these bromoacetate derivatives indicated significant changes in the A-ring conformations of these analogs. These structural changes were invoked to explain the inability of [3H]-1alpha,25(OH)2D3-1-BE and [3H]-1alpha,25(OH)2D3-1,3-di-BE to affinity label DBP. Overall, these studies suggested that the vitamin D sterol-binding pocket in DBP is sterically quite restrictive. This information could be potentially important in designing future vitamin D-based drugs for several diseases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9200691     DOI: 10.1021/bi962730i

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  5 in total

1.  Selective inhibition of the C5a chemotactic cofactor function of the vitamin D binding protein by 1,25(OH)2 vitamin D3.

Authors:  Anisha B Shah; Stephen J DiMartino; Glenda Trujillo; Richard R Kew
Journal:  Mol Immunol       Date:  2005-08-22       Impact factor: 4.407

2.  Identification of two distinct cell binding sequences in the vitamin D binding protein.

Authors:  Jianhua Zhang; David M Habiel; Mahalakshmi Ramadass; Richard R Kew
Journal:  Biochim Biophys Acta       Date:  2010-03-06

3.  All-trans retinol, vitamin D and other hydrophobic compounds bind in the axial pore of the five-stranded coiled-coil domain of cartilage oligomeric matrix protein.

Authors:  Y Guo; D Bozic; V N Malashkevich; R A Kammerer; T Schulthess; J Engel
Journal:  EMBO J       Date:  1998-09-15       Impact factor: 11.598

4.  Synthesis and characterization of deoxycholyl 2-deoxyglucuronide: a water-soluble affinity labeling reagent.

Authors:  Nariyasu Mano; Akira Nishijima; Shuntaro Saito; Shigeo Ikegawa; Junichi Goto
Journal:  Lipids       Date:  2003-08       Impact factor: 1.880

5.  A 12 kb multi-allelic copy number variation encompassing a GC gene enhancer is associated with mastitis resistance in dairy cattle.

Authors:  Young-Lim Lee; Haruko Takeda; Gabriel Costa Monteiro Moreira; Latifa Karim; Erik Mullaart; Wouter Coppieters; Ruth Appeltant; Roel F Veerkamp; Martien A M Groenen; Michel Georges; Mirte Bosse; Tom Druet; Aniek C Bouwman; Carole Charlier
Journal:  PLoS Genet       Date:  2021-07-21       Impact factor: 5.917

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.